To Development a Live Attenuated Vaccine Against Coccidioidomycosis Through a Phase 1 Clinical Trial That Will Demonstrate Safety and Immunogenicity in Healthy Subjects Without Prior Exposure to the C

Activity Type
Research
Date
Dollar Amount
705,508.00
Grant Type
Contract
Principal Investigator
John Galgiani
Sponsor
Anivive Lifesciences, Inc
Unit
Valley Fever Ctr for Excellnc